Events Calendar

The recent announcement of a new antiviral called molnupiravir that might reduce the severity and lethality of COVID infection has triggered great interest. 

During the webcast, Healthed will look at the current data on it, what the implications would be for its application here in Australia as well as overseas. And, a quick look at other candidates that might be in the development pipeline. 

Register for this Event here